Financial statements Onkologiczna Pracownia Molekularna

Balance sheet of Onkologiczna Pracownia Molekularna

Company age:
Age:
17 y. 5 m. 6 d.
Share capital:
Share capital:
50 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of ONKOLOGICZNA PRACOWNIA MOLEKULARNA

Year
2018
2019
2021
2022
2023
Total assets 178 571,07 57 264,77 4 476 615,60 2 436 896,76 1 710 300,93
A. Fixed assets 41 032,90 50 497,85 2 433 542,47 2 316 496,63 1 627 814,75
B. Current assets 137 538,17 6 766,92 2 043 073,13 120 400,13 82 486,18
C. Share capital contributions (basic funds) - - - - -
D. Own shares (stocks) - - - - -
Total liabilities 178 571,07 57 264,77 4 476 615,60 2 436 896,76 1 710 300,93
A. Equity 23 431,70 -197 674,24 3 920 298,00 1 646 690,98 347 755,35
B. Liabilities and provisions for liabilities 155 139,37 254 939,01 556 317,60 790 205,78 1 362 545,58
I. Long-term liabilities 0,00 12 000,00 12 000,00 12 000,00 297 000,00
II. Short-term liabilities 155 139,37 242 939,01 544 317,60 778 205,78 797 565,48
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.